Global Therapeutic Vaccines Market- Trends And Forecasts (2016 - 2021)

  • ID: 2981267
  • Report
  • Region: Global
  • 117 pages
  • Mordor Intelligence
1 of 4
Global Vaccine Market Expected to Grow by a CAGR of Close to 12.4 % Till the Year 2020.

FEATURED COMPANIES

  • Glaxosmithkline
  • Merck
  • Novartis
  • Pfizer
  • Sanofi Avnetis
  • Serum Institute
  • MORE
The vaccine market accounts for a relatively small share (2-3%) of the global pharmaceutical market sales. However, there has been rapid growth over recent years, with the vaccine market quadrupling in value from USD 5 billion in 2000 to almost USD 24 billion in 2013. Once a commodity market with low margins, the vaccines on the market now include blockbusters and mega blockbusters. New candidates for vaccinating against cancers and HIV are also projected to hit the magic milestone.

Multinational vaccine companies historically have conducted much of the innovation, research, and development in the field of vaccine production. They have used significant revenues, global size, and deeper expertise to fund. The development of new technologies for vaccine development – an expensive and relatively time consuming process. But Despite the success of vaccines, infectious diseases are still a major cause of illnesses worldwide and at least 40 major infectious diseases are still uncontrolled by vaccination.

There are currently close 120 new vaccines in the pipeline of various companies across the globe set to hit the market in the next 5 years to come. In anticipation of this and with the emergence of new target market and smaller player into the market, the Global vaccine market is set to grow by a CAGR of close to 12.4 % till the year 2020.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Glaxosmithkline
  • Merck
  • Novartis
  • Pfizer
  • Sanofi Avnetis
  • Serum Institute
  • MORE
1. Introduction
1.1 Overview
1.2 Market Definition
1.3 Market Trends

2. Executive Summary

3. Global Therapeutic Proteins Market – Industry Analysis
3.1 Market Drivers
3.1.1 Increasing demand , higher onset of diseases
3.1.2 Government funded projects and associations
3.1.3 Higher profitability and improved technology
3.2 Market opportunities
3.2.1 New Target populations- shift from established markets to lesser developed markets
3.3 Market Constraints
3.3 .1 Risk of adverse effects
3.3.3 High regulatory Intervention and cost

4. Types of Vaccines
I. Live, attenuated vaccines
II. Inactivated vaccines
III. Subunit vaccines
IV. Toxoid vaccines
V. Conjugate vaccines
VI. DNA vaccines
VII. Recombinant vector vaccines

5. Vaccine market by application ( Market Size , Forecast, CAGR)
5.1 Pediatric Vaccines
5.1.1 Pneumococcal
5.1.2 Varicella
5.1.3 Combinations
5.1.3.1 Bivalent
5.1.3.2 Trivalent
5.1.3.3 Tetravalent
5.1.3.4 Pentavalent
5.1.4 MMR
5.1.5 Poliovirus
5.1.6 Hepatitis
5.1.7 HIB
5.1.8 Other Pediatric
5.2 Adult Vaccines
5.2.1 Influenza
5.2.2 Cervical Cancer
5.2.3 Hepatitis
5.2.4 Zoster
5.2.5 Other adult vaccines

6. Regional Analysis of the Vaccine market
6.1 North America (Market Size, Forecast and CAGR)
6.1.1 USA
6.1.2 Canada
6.1.3 Rest of north America
6.2 Europe (Market Size, Forecast and CAGR)
6.2.1 Germany
6.2.2 France
6.2.3 UK
6.2.4 Italy
6.2.5 Spain
6.2.6 Rest of Europe
6.3 Asia Pacific (Market Size, Forecast and CAGR)
6.3.1 China
6.3.2 India
6.3.3 Japan
6.3.4 Rest of Asia
6.4 Rest of the World(Market Size, Forecast and CAGR)

7. Competitive Landscape
7.1 Current Market trends In Vaccines
7.2 Future of Vaccines
7.3 Joint Ventures
7.4 Mergers and Acquisitions
7.5 PentAct HIB, Quinvaxem and the future of Pentavalent vaccines

8. Key Company Profiles
8.1 Sanofi Avnetis
8.2 Merck
8.3 Glaxosmithkline
8.4 Novartis
8.5 Pfizer
8.6 Serum institute

9. List Of tables

10. List of Figures

11. Appendix
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Glaxosmithkline
- Merck
- Novartis
- Pfizer
- Sanofi Avnetis
- Serum Institute
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll